-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Total costs of sales and operating expenses for the period.
-
Summary
-
Biocryst Pharmaceuticals Inc quarterly/annual Costs and Expenses history and growth rate from 2010 to 2023.
- Biocryst Pharmaceuticals Inc Costs and Expenses for the quarter ending September 30, 2024 was $109M, a 10.9% increase year-over-year.
- Biocryst Pharmaceuticals Inc Costs and Expenses for the twelve months ending September 30, 2024 was $453M, a 6.68% increase year-over-year.
- Biocryst Pharmaceuticals Inc annual Costs and Expenses for 2023 was $435M, a 3.78% increase from 2022.
- Biocryst Pharmaceuticals Inc annual Costs and Expenses for 2022 was $419M, a 25.2% increase from 2021.
- Biocryst Pharmaceuticals Inc annual Costs and Expenses for 2021 was $335M, a 73.9% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Growth (%)